Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells

Molecular Cancer

Volumn 8, Issue , 2009, Pages 90-

  Yuzugullu, Haluk ^a,b   Benhaj, Khemais ^a,c   Ozturk, Nuri ^a   Senturk, Serif ^a   Celik, Emine ^d   Toylu, Asli ^d   Tasdemir, Nilgun ^a   Yilmaz, Mustafa ^a   Erdal, Esra ^a,d   Akcali, Kamil C ^a   Atabey, Nese ^d   Ozturk, Mehmet ^a,b  

^a BILKENT UNIVERSITY   (Turkey)

^b UNIV GRENOBLE ALPES   (France)

^c CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

^d DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; FRIZZLED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; LYMPHOID ENHANCER FACTOR 1; TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR 7; UNCLASSIFIED DRUG; WNT PROTEIN; WNT4 PROTEIN; WNT5A PROTEIN; WNT5B PROTEIN; WNT7B PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOMA CELL; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

AUTOCRINE COMMUNICATION; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL NUCLEUS; FRIZZLED RECEPTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; LIVER NEOPLASMS; MUTATION; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, LDL; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; WNT PROTEINS;

EID: 70450228519     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-8-90     Document Type: Article

References (74)

1. Bruix J, Boix L, Sala M, Llovet JM. Focus on hepatocellular carcinoma. Cancer Cell 2004, 5:215-219. 10.1016/S1535-6108(04)00058-3, 15050913.
2. Kojiro M. Histopathology of liver cancers. Best Pract Res Clin Gastroenterol 2005, 19:39-62. 10.1016/j.bpg.2004.10.007, 15757804.
3. Abelev GI, Lazarevich NL. Control of differentiation in progression of epithelial tumors. Adv Cancer Res 2006, 95:61-113. 10.1016/S0065-230X(06)95003-9, 16860656.
4. Hsu HC, Wu TT, Wu MZ, Sheu JC, Lee CS, Chen DS. Tumor invasiveness and prognosis in resected hepatocellular carcinoma. Clinical and pathogenetic implications. Cancer 1988, 61:2095-2099. 10.1002/1097-0142(19880515)61:10<2095::AID-CNCR2820611027>3.0.CO;2-H, 2834037.
5. Osada T, Sakamoto M, Ino Y, Iwamatsu A, Matsuno Y, Muto T, Hirohashi S. E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology 1996, 24:1460-1467. 10.1002/hep.510240627, 8938181.
6. Sugimachi K, Tanaka S, Kameyama T, Taguchi K, Aishima S, Shimada M, Tsuneyoshi M. Transcriptional repressor snail and progression of human hepatocellular carcinoma. Clin Cancer Res 2003, 9:2657-2664.
7. Lee TK, Poon RT, Yuen AP, Ling MT, Kwok WK, Wang XH, Wong YC, Guan XY, Man K, Chau KL, Fan ST. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 2006, 12:5369-5376. 10.1158/1078-0432.CCR-05-2722, 17000670.
8. Hu L, Lau SH, Tzang CH, Wen JM, Wang W, Xie D, Huang M, Wang Y, Wu MC, Huang JF. Association of Vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene 2004, 23:298-302. 10.1038/sj.onc.1207150, 14647434.
9. Cicchini C, Filippini D, Coen S, Marchetti A, Cavallari C, Laudadio I, Spagnoli FM, Alonzi T, Tripodi M. Snail controls differentiation of hepatocytes by repressing HNF4alpha expression. J Cell Physiol 2006, 209:230-238. 10.1002/jcp.20730, 16826572.
10. Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 2005, 129:1375-1383. 10.1053/j.gastro.2005.09.055, 16285938.
11. Lee HC, Tian B, Sedivy JM, Wands JR, Kim M. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology 2006, 131:1208-1217. 10.1053/j.gastro.2006.07.012, 2593881, 17030190.
12. Fuchs BC, Fujii T, Dorfman JD, Goodwin JM, Zhu AX, Lanuti M, Tanabe KK. Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Res 2008, 68:2391-2399. 10.1158/0008-5472.CAN-07-2460, 18381447.
13. Lahsnig C, Mikula M, Petz M, Zulehner G, Schneller D, van Zijl F, Huber H, Csiszar A, Beug H, Mikulits W. ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression. Oncogene 2009, 28:638-650. 10.1038/onc.2008.418, 19015638.
14. Matsuo N, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Tanaka S, Nishina S, Nakanishi Y, Uemura M, Takaki A. Twist expression promotes migration and invasion in hepatocellular carcinoma. BMC Cancer 2009, 9:240. 10.1186/1471-2407-9-240, 2720986, 19615090.
15. Miyoshi A, Kitajima Y, Sumi K, Sato K, Hagiwara A, Koga Y, Miyazaki K. Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br J Cancer 2004, 90:1265-1273. 10.1038/sj.bjc.6601685, 2409652, 15026811.
16. Parviz F, Matullo C, Garrison WD, Savatski L, Adamson JW, Ning G, Kaestner KH, Rossi JM, Zaret KS, Duncan SA. Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet 2003, 34:292-296. 10.1038/ng1175, 12808453.
17. Battle MA, Konopka G, Parviz F, Gaggl AL, Yang C, Sladek FM, Duncan SA. Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci USA 2006, 103:8419-8424. 10.1073/pnas.0600246103, 1482507, 16714383.
18. Lazarevich NL, Cheremnova OA, Varga EV, Ovchinnikov DA, Kudrjavtseva EI, Morozova OV, Fleishman DI, Engelhardt NV, Duncan SA. Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Hepatology 2004, 39:1038-1047. 10.1002/hep.20155, 15057908.
19. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002, 31:339-346. 10.1038/ng0802-339, 12149612.
20. Hsu HC, Jeng YM, Mao TL, Chu JS, Lai PL, Peng SY. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am J Pathol 2000, 157:763-770. 1885685, 10980116.
21. Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 2002, 21:4863-4871. 10.1038/sj.onc.1205591, 12101426.
22. Audard V, Grimber G, Elie C, Radenen B, Audebourg A, Letourneur F, Soubrane O, Vacher-Lavenu MC, Perret C, Cavard C, Terris B. Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations. J Pathol 2007, 212:345-352. 10.1002/path.2169, 17487939.
23. Mao TL, Chu JS, Jeng YM, Lai PL, Hsu HC. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis. J Pathol 2001, 193:95-101. 10.1002/1096-9896(2000)9999:9999<::AID-PATH720>3.0.CO;2-3, 11169521.
24. Wong CM, Fan ST, Ng IO. beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer 2001, 92:136-145. 10.1002/1097-0142(20010701)92:1<136::AID-CNCR1301>3.0.CO;2-R, 11443619.
25. Laurent-Puig P, Zucman-Rossi J. Genetics of hepatocellular tumors. Oncogene 2006, 25:3778-3786. 10.1038/sj.onc.1209547, 16799619.
26. Calvisi DF, Factor VM, Loi R, Thorgeirsson SS. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade. Cancer Res 2001, 61:2085-2091.
27. Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 2006, 5:997-1014. 10.1038/nrd2154, 17139285.
28. Cadoret A, Ovejero C, Terris B, Souil E, Levy L, Lamers WH, Kitajewski J, Kahn A, Perret C. New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene 2002, 21:8293-8301. 10.1038/sj.onc.1206118, 12447692.
29. Harada N, Miyoshi H, Murai N, Oshima H, Tamai Y, Oshima M, Taketo MM. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin. Cancer Res 2002, 62:1971-1977.
30. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, Taketo MM. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J 1999, 18:5931-5942. 10.1093/emboj/18.21.5931, 1171659, 10545105.
31. Ishiyama T, Kano J, Minami Y, Iijima T, Morishita Y, Noguchi M. Expression of HNFs and C/EBP alpha is correlated with immunocytochemical differentiation of cell lines derived from human hepatocellular carcinomas, hepatoblastomas and immortalized hepatocytes. Cancer Sci 2003, 94:757-763. 10.1111/j.1349-7006.2003.tb01515.x, 12967472.
32. Du GS, Wang JM, Lu JX, Li Q, Ma CQ, Du JT, Zou SQ. Expression of P-aPKC-iota, E-cadherin, and beta-catenin related to invasion and metastasis in hepatocellular carcinoma. Ann Surg Oncol 2009, 16:1578-1586. 10.1245/s10434-009-0423-7, 19290490.
33. Wang W, Hayashi Y, Ninomiya T, Ohta K, Nakabayashi H, Tamaoki T, Itoh H. Expression of HNF-1 alpha and HNF-1 beta in various histological differentiations of hepatocellular carcinoma. J Pathol 1998, 184:272-278. 10.1002/(SICI)1096-9896(199803)184:3<272::AID-PATH4>3.0.CO;2-K, 9614379.
34. Niu RF, Zhang L, Xi GM, Wei XY, Yang Y, Shi YR, Hao XS. Up-regulation of Twist induces angiogenesis and correlates with metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res 2007, 26:385-394.
35. Staal FJ, Luis TC, Tiemessen MM. WNT signalling in the immune system: WNT is spreading its wings. Nat Rev Immunol 2008, 8:581-593. 10.1038/nri2360, 18617885.
36. Bafico A, Liu G, Goldin L, Harris V, Aaronson SA. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 2004, 6:497-506. 10.1016/j.ccr.2004.09.032, 15542433.
37. Mikels AJ, Nusse R. Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 2006, 4:e115. 10.1371/journal.pbio.0040115, 1420652,1420652, 16602827.
38. Nemeth MJ, Topol L, Anderson SM, Yang Y, Bodine DM. Wnt5a inhibits canonical Wnt signaling in hematopoietic stem cells and enhances repopulation. Proc Natl Acad Sci USA 2007, 104:15436-15441. 10.1073/pnas.0704747104, 1986571,1986571, 17881570.
39. Ishitani T, Kishida S, Hyodo-Miura J, Ueno N, Yasuda J, Waterman M, Shibuya H, Moon RT, Ninomiya-Tsuji J, Matsumoto K. The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol Cell Biol 2003, 23:131-139. 10.1128/MCB.23.1.131-139.2003, 140665, 12482967.
40. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997, 275:1787-1790. 10.1126/science.275.5307.1787, 9065402.
41. Erdal E, Ozturk N, Cagatay T, Eksioglu-Demiralp E, Ozturk M. Lithium-mediated downregulation of PKB/Akt and cyclin E with growth inhibition in hepatocellular carcinoma cells. Int J Cancer 2005, 115:903-910. 10.1002/ijc.20972, 15723355.
42. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 2000, 24:245-250. 10.1038/73448, 10700176.
43. Cagatay T, Ozturk M. P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells. Oncogene 2002, 21:7971-7980. 10.1038/sj.onc.1205919, 12439747.
44. Brantjes H, Roose J, Wetering M, Clevers H. All Tcf HMG box transcription factors interact with Groucho-related co-repressors. Nucleic Acids Res 2001, 29:1410-1419. 10.1093/nar/29.7.1410, 31284, 11266540.
45. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 1995, 92:3046-3050. 10.1073/pnas.92.7.3046, 42356, 7708772.
46. McDonald SL, Silver A. The opposing roles of Wnt-5a in cancer. Br J Cancer 2009, 101:209-214. 10.1038/sj.bjc.6605174, 19603030.
47. Nejak-Bowen K, Monga SP. Wnt/beta-catenin signaling in hepatic organogenesis. Organogenesis 2008, 4:92-99. 2634254, 19279720.
48. Hu M, Kurobe M, Jeong YJ, Fuerer C, Ghole S, Nusse R, Sylvester KG. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells. Gastroenterology 2007, 133:1579-1591. 10.1053/j.gastro.2007.08.036, 17983805.
49. Apte U, Thompson MD, Cui S, Liu B, Cieply B, Monga SP. Wnt/beta-catenin signaling mediates oval cell response in rodents. Hepatology 2008, 47:288-295. 10.1002/hep.21973, 17929301.
50. Yang W, Yan HX, Chen L, Liu Q, He YQ, Yu LX, Zhang SH, Huang DD, Tang L, Kong XN. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res 2008, 68:4287-4295. 10.1158/0008-5472.CAN-07-6691, 18519688.
51. Lee JS, Thorgeirsson SS. Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer. Hepatology 2002, 35:1134-1143. 10.1053/jhep.2002.33165, 11981763.
52. Armengol C, Cairo S, Fabre M, Buendia MA. Wnt signaling and hepatocarcinogenesis: The hepatoblastoma model. Int J Biochem Cell Biol 2009,
53. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119:1420-1428. 10.1172/JCI39104, 19487818.
54. Zeng G, Awan F, Otruba W, Muller P, Apte U, Tan X, Gandhi C, Demetris AJ, Monga SP. Wnt'er in liver: expression of Wnt and frizzled genes in mouse. Hepatology 2007, 45:195-204. 10.1002/hep.21473, 17187422.
55. Merle P, Kim M, Herrmann M, Gupte A, Lefrancois L, Califano S, Trepo C, Tanaka S, Vitvitski L, de la Monte S, Wands JR. Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma. J Hepatol 2005, 43:854-862. 10.1016/j.jhep.2005.05.018, 16098625.
56. Kim M, Lee HC, Tsedensodnom O, Hartley R, Lim YS, Yu E, Merle P, Wands JR. Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells. J Hepatol 2008, 48:780-791. 10.1016/j.jhep.2007.12.020, 2390890, 18313787.
57. Bengochea A, de Souza MM, Lefrancois L, Le Roux E, Galy O, Chemin I, Kim M, Wands JR, Trepo C, Hainaut P. Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer 2008, 99:143-150. 10.1038/sj.bjc.6604422, 2453022, 18577996.
58. Yoshikawa H, Matsubara K, Zhou X, Okamura S, Kubo T, Murase Y, Shikauchi Y, Esteller M, Herman JG, Wei Wang X, Harris CC. WNT10B functional dualism: beta-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer. Mol Biol Cell 2007, 18:4292-4303. 10.1091/mbc.E06-10-0889, 2043567, 17761539.
59. Liu XH, Pan MH, Lu ZF, Wu B, Rao Q, Zhou ZY, Zhou XJ. Expression of Wnt-5a and its clinicopathological significance in hepatocellular carcinoma. Dig Liver Dis 2008, 40:560-567. 10.1016/j.dld.2007.12.011, 18294932.
60. Liu X, Wang L, Zhang S, Lin J, Feitelson MA, Gao H, Zhu M. Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses. Carcinogenesis 2008, 29:1207-1214. 10.1093/carcin/bgn111, 2443277, 18477650.
61. Wei W, Chua MS, Grepper S, So S. Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo. Int J Cancer 2009,
62. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434:843-850. 10.1038/nature03319, 15829953.
63. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, Nakauchi H, Taniguchi H. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006, 44:240-251. 10.1002/hep.21227, 16799977.
64. Roarty K, Baxley SE, Crowley MR, Frost AR, Serra R. Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype. Breast Cancer Res 2009, 11:R19. 10.1186/bcr2244, 2688948, 19344510.
65. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 2003, 162:899-908. 10.1083/jcb.200303158, 2172823, 12952940.
66. Shimizu H, Julius MA, Giarre M, Zheng Z, Brown AM, Kitajewski J. Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth Differ 1997, 8:1349-1358.
67. Taki M, Kamata N, Yokoyama K, Fujimoto R, Tsutsumi S, Nagayama M. Down-regulation of Wnt-4 and up-regulation of Wnt-5a expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Cancer Sci 2003, 94:593-597. 10.1111/j.1349-7006.2003.tb01488.x, 12841867.
68. Dissanayake SK, Wade M, Johnson CE, O'Connell MP, Leotlela PD, French AD, Shah KV, Hewitt KJ, Rosenthal DT, Indig FE. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem 2007, 282:17259-17271. 10.1074/jbc.M700075200, 2263117, 17426020.
69. Ripka S, Konig A, Buchholz M, Wagner M, Sipos B, Kloppel G, Downward J, Gress T, Michl P. WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis 2007, 28:1178-1187. 10.1093/carcin/bgl255, 17227781.
70. Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 2009, 136:1012-1024. 10.1053/j.gastro.2008.12.004, 19150350.
71. Benhamouche S, Decaens T, Godard C, Chambrey R, Rickman DS, Moinard C, Vasseur-Cognet M, Kuo CJ, Kahn A, Perret C, Colnot S. Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. Dev Cell 2006, 10:759-770. 10.1016/j.devcel.2006.03.015, 16740478.
72. Burke ZD, Reed KR, Phesse TJ, Sansom OJ, Clarke AR, Tosh D. Liver zonation occurs through a beta-catenin-dependent, c-Myc-independent mechanism. Gastroenterology 2009, 136:2316-2324. e2311-2313, 10.1053/j.gastro.2009.02.063, 19268669.
73. Chien AJ, Moore EC, Lonsdorf AS, Kulikauskas RM, Rothberg BG, Berger AJ, Major MB, Hwang ST, Rimm DL, Moon RT. Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci USA 2009, 106:1193-1198. 10.1073/pnas.0811902106, 2626610,2626610, 19144919.
74. Riou P, Saffroy R, Chenailler C, Franc B, Gentile C, Rubinstein E, Resink T, Debuire B, Piatier-Tonneau D, Lemoine A. Expression of T-cadherin in tumor cells influences invasive potential of human hepatocellular carcinoma. FASEB J 2006, 20:2291-2301. 10.1096/fj.06-6085com, 17077306.